Assistant Professor, Medicine, University of Oklahoma College of Medicine
Hematology
Dr. Carla Kurkjian, MD
|
|
Give Review
Carla Kurkjian, MD practices Hematology. She researched medicine at University of Oklahoma College of Medicine. Dr. Carla Kurkjian has written publications. She has 15 publications published with PubMed. The lastest paper is: 'A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer.' Dr. Carla Kurkjian is registered with Medicare and accepts Medicare payments.
Publications
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced Cancer.
- A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid Tumors.
- Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid Tumors.
- A Phase I Dose Escalation Study of Oral c-MET Inhibitor Tivantinib (ARQ 197) in Combination with Gemcitabine in Patients with Solid Tumors.
- Antitumor Activity of an Enzyme Prodrug Therapy Targeted to the Breast Tumor Vasculature.
- A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid Tumors.
- Topics in clinical pharmacology: renal, gastrointestinal, and pain management.
- Advances in the treatment of metastatic colorectal Cancer.
- DNA methylation: its role in Cancer development and therapy.
- The observation that changes in DNA methylation potentially play a role in neoplastic transformation has existed for nearly 30 years. Foreword.
- Treatment of recurrent metastatic colon Cancer in the age of modern adjuvant therapy.
- Cytogenetic changes associated with myelodysplastic syndrome affecting bone marrow engraftment Analysis.
- Acute promyelocytic leukemia and constitutional trisomy 21.
- Symptomatic metastases to the pituitary infundibulum resulting from primary breast Cancer.
Schools
University of Oklahoma Health Sciences Center
Ou
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Oklahoma College of Medicine
Drug Facts
| NPI NUMBER | 1760534127 | |
| NPPES Provider LastName | KURKJIAN | |
| NPPES Provider FirstName | CARLA | |
| NPPES Provider ZIPCode | 731045418 | |
| NPPES Provider State | OK | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 727.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 79.0 | |
| Percent Opioid Claims | 10.87 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760534127 |
| Last Name Of The Provider | KURKJIAN |
| First Name Of The Provider | CARLA |
| View All |
Similar Doctors
|
|
Dr. Michael J. Keefer, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Lara Theobald, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shubham Pant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mohammad Razaq, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Clinton A. Medbery III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Hampton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hiral D. Parekh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bilal Ahmad, MD |
|
|
Dr. Sobia Nabeel, MD
This Doctor is OpenDoctor Recommended.
|